Mott retires from NEA

By Sandi Wong, Assistant Editor | Mar 5, 2020 | 1:52 AM GMT

Dave Mott, the former Smith Barney investment banker, CEO of MedImmune and longtime VC, has announced his retirement from New Enterprise